Midatech Pharma Share Discussion Threads

[deltrotter] 19/3/2016 12:15

Agreed Hutch_Pod. I'd expect some news in their results mid-April.

The slide here is not nice, but I am very happy to pick up more.

[hutch_pod] 18/3/2016 23:00

Thanks deltrotter, missed that. Roll on April and fingers crossed solid diabetes trial results. Has been some serious drift in the meantime.

[deltrotter] 18/3/2016 16:18

For long term holders:

[hutch_pod] 13/3/2016 19:47

Good interview. Liked hearing his view on the share price and Dara shareholder profit taking. Hope April delivers good progress.

[deltrotter] 10/3/2016 17:12

Much appreciated ipoman.

[ipoman007] 10/3/2016 14:44

Midatech CEO discusses the 'unheard of' progress with MTX110 cancer treatment. Also Jim passionate about staying in EU: hxxps://goo.gl/TtPJtJ
Also Jim discusses outlook in the view of the 150% rise in shares forecast by N+ Singer and Panmure Gordon

[deltrotter] 09/3/2016 20:38

Really fantastic presentation that guys. Looks to be news on the way early April.

[deltrotter] 09/3/2016 16:49

The gaffer speaking at Biotech Capital Conference on 3rd March:

[toolsmoker] 18/1/2016 20:44

150 here again looks like

[deltrotter] 12/1/2016 08:39

Presentation from yesterday in the US by the gaffer:

[toolsmoker] 07/1/2016 08:49

Should be 250 minimum now free money buying here in my opinion

[luffness] 06/1/2016 10:27

totally agree - the recent shambles turned into quite an opportunity

[toolsmoker] 06/1/2016 10:25

Should be 300p this stock may have to wait till April but no brainer

[luffness] 02/1/2016 10:23

"Highly-respected veteran City commentator David Buik tells investors which shares and trends investors should keep an eye on in 2016.

What are your favourite blue-chip shares and why?

On a personal basis I'm not allowed to make stock recommendations, but I can tell you what the various people at Panmure Gordon recommend.

There is a strong liking for technology and there are three stocks we like a lot. One is Microfocus (MCRO) and the other is Midatech (MTPH), which is again partly technology and partly pharmaceutical. It's done very well and we have huge aspirations for it. The other is Fusionex International (FXI)."

While i share the aspirations i am not sure how accurate the "its done very well claim" is which kind of makes you question their credibility

[deltrotter] 30/12/2015 10:04

Tx hutch, I bought nearly 3k early doors

edit - and just added another 500.

I'll be looking forward to this being a healthy dividend payer in 5 years time.

[hutch_pod] 30/12/2015 09:57

Did you see this from 17th?



High time for an update on this article: the merger has been approved, the ADR's have been issued, but the idea so far hasn't worked out like I had planned. One of the risks highlighted in the article was:

"Midatech's ADRs trading in tandem with its Ordinary Shares could cause the price of the ADRs to go up, but the same mechanism could obviously also cause the price of the Ordinary Shares in the UK to go down."

Unfortunately, this is what happened. Since the deal was completed the MTPH share price in London took a bath and has now dropped close to 25% in about two weeks, making this deal a nightmare for the UK holders. I indicated in the article MTPH was illiquid and unshortable; I knew the shares in London would likely drop as a result of ADR-holders converting and selling, explaining some of the premium to the US price. But I hadn't expected an <20M take over to cause MTPH to shed >30M in market cap which in itself is of course fundamentally questionable; Midatech + DARA combined is now worth less than Midatech itself used to do. Also, trading volumes were horrendously low.

I had expected MTPH-management, or any of its many experienced institutional investors, to see this coming based on the illiquidity of MTPH-shares, and to have at least something of contingency plan ready. Apparently so far they didn't. One would assume experienced investors like Neil Woodford (who holds an 18% stake through Woodford Investment Management) would not allow his fund to lose millions in a few days on trading volumes of about 40K $ without stepping in. One would also assume he, or any one of the other holders being hung out to dry, still will. It wouldn't take much.

Anyway, with regards to ADR conversion: no US listed ADR I'm aware of trades at a discount to its UK listed peers, and MTP won't either in the mid term

[toolsmoker] 24/12/2015 09:31

I'm calling the bottom here guys load up

[njw2] 23/12/2015 12:30

Wonder when the company going to pull there finger out and inform shareholders what the hell is going

[deltrotter] 22/12/2015 09:05

No, just email hutch. Would be good if someone else could try.

[hutch_pod] 22/12/2015 08:46

That is really bad. Did you try the phone number?